April 13, 2026
A team of Weill Cornell Medicine investigators is working to cross-train the next generation of cancer researchers in cancer biology and the use of artificial intelligence tools for research.
Dr. Olivier Elemento. Credit: Brad Trent
“AI is transforming our world—how we work, live and conduct research,” said Dr. Olivier Elemento, director of the Englander Institute for Precision Medicine and a professor of systems and computational biomedicine. He added that “cancer is uniquely positioned to benefit, because we now have massive datasets spanning genomics, imaging and clinical outcomes that AI can finally put to use.”